American Journal of Psychiatry · 1989 · 342 citations · 16 references
MedicinePharmacologyPharmacotherapyDementiaNeuropharmacologyPsychopharmacologyAlzheimer DiseaseAntidepressant PharmacotherapyDementia PharmacotherapyDementia TreatmentDepression PharmacotherapyNeurodegenerative Disease PharmacotherapyAlzheimer Disease DementiaAntidepressant Use In DementiaDepression In DementiaDouble-blind TrialsPharmacological Treatment Of Dementia
The authors divided 61 subjects with primary degenerative dementia of the Alzheimer's type into a group who also met DSM-III criteria for depression (N = 28) and a group who did not (N = 33). Both groups were randomly assigned to an 8-week double-blind trial of imipramine or placebo. Scores on the Hamilton Rating Scale for Depression, administered at baseline and weeks 2, 4, 6, and 8, indicated significant improvement in both groups. Two measures of cognitive function yielded differing results. The results suggest that moderate depression is a treatable condition in patients with Alzheimer's disease.
16
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
L. G. Kiloh · Acta Psychiatrica Scandinavica · 1961 · 361 citations
Depression in Patients Referred to a Dementia Clinic
Michael Reding · Archives of Neurology · 1985 · 326 citations
Medicine, Neurology, Psychiatry +17